近年来,与肺癌复发转移相关微小RNA (miRNA)的临床研究取得了重要进展.在PubMed上检索与非小细胞肺癌(NSCLC)术后复发转移相关的miRNA临床研究文献,结果发现miRNA 在肺癌中具有差异性表达,部分已揭示与术后复发转移预后相关,可以作为今后的治疗靶点.但目前临床研究中发现的与NSCLC术后复发转移相关的miRNA,绝大部分尚处在筛选阶段,缺少大样本的临床验证,尤其是随机、对照研究.
microRNAs (miRNAs) related to the recurrence and metastasis of non-small-cell lung cancer (NSCLC) in recent years have made important progress.The authors search the clinical researches related to the link between the miRNA and the recurrence and metastasis of postoperative NSCLC on PubMed.The clinical studies produced contradictory data.miRNA differentially expressed in lung cancer based on their data.Some but not all suggested that the miRNA is associated with the metastasis and recurrence of NSCLC,suggesting the miRNA could be a potential therapeutic targets for therapy of lung cancers.However,most studies are still at the screening stage,which is lack of a large group of patients,especially in random,controlled study to verify the miRNA predict recurrence transfer orientation or prognosis,which can be the direction for the practice of clinical trials in the future.